Sign in: Staff/Students
Tomorrow is World Cancer Day (WCD), which takes place every year on 4 February.
Founded in 2005, WCD is one singular initiative allowing cancer charities, researchers, health care workers, businesses and governments to unite in the fight against the global cancer epidemic.
Since last year’s WCD we’ve published a number of news stories highlighting the developments in cancer-related research here at the University.
From working to increase the survival times of lung and pancreatic cancer patients, challenging health inequalities linked to cancer, to the development of a machine that can ‘smell’ certain cancers, we round up some of our cancer related research updates from the past 12 months.
A major lung cancer screening trial found that patients with a high risk of developing lung cancer can be identified with early stage disease and have up to a 73% chance of surviving five years or more.
Head and neck cancers
In the first study of its kind researchers examined the possible reasons for the rapid increase in incidence of particular head and neck cancers in the UK.
The University partnered in a new European Consortium to foster research on eye cancer and identify new treatments for this serious disease.
A landmark clinical trial found that 29% of pancreatic cancer patients given a combination of two chemotherapy drugs lived for at least five years compared with 16% who received the one chemotherapy drug.
Scientists reached a major milestone towards the development of a machine that can detect prostate cancer by ‘smelling’ urine. This urine diagnostic test could mean the invasive diagnostic procedures that men currently undergo eventually become a thing of the past.
New research showed that deprived groups in England consume more salt and as a result are at higher risk of developing gastric cancer.
Two UK clinical trials led by the University started to test potential new drug treatments for early and advanced types of breast cancer.
In the past 12 months the University has received in excess of £5m worth of investment for research into nine different types of cancer.
Recently, leading research charity Cancer Research UK and the National Institute for Health Research (NIHR) announced their plan to invest nearly £1.5M over the next five years in ground-breaking work at the Liverpool Experimental Cancer Medicine Centre (ECMC).
Also, the North West Cancer Research Centre – University of Liverpool (NWCR Centre – UoL) received an extension of its funding until the end of this year. This brings the total of funding for the Cancer Research Centre from NWCR to approximately £1.5M over the last three-and-a-half years, allowing for the continuation of high-quality basic and translational research by its scientists, and of its outreach activities.
Read more about our cancer related research here https://news.liverpool.ac.uk/tag/cancer/
You must be logged in to post a comment.
All recent news
Staff Awards 2022 winners announced at Liverpool World Museum
New Researchers at Risk Scheme – Open for Ukrainian Applicants
Students in the community: Being a good neighbour
National Student Survey results published
University of Liverpool appoints new Vice-Chancellor
We are delighted to announce that Professor Tim Jones will be our next Vice-Chancellor from January 2023.
Daily testing saved Liverpool's emergency services from Covid catastrophe - new findings published by @eClinicalMed revealed world’s first testing pilot saved almost 8,000 work days from being lost to self-isolation. Full story➡️http://bit.ly/3OZ2F9W #teamscience #teamliverpool
Today @CERN's #LargeHadronCollider will start delivering proton collisions to experiments at an unprecedented energy of 13.6 TeV.
Our @livuniphysics are part of the international collaboration that will collect & analyse the data ➡️http://bit.ly/3NSiVcc #LHCRun3